More than 2% of Americans are taking the blockbuster class of GLP-1 drugs for overweight or obesity, up nearly 600% over six years, according to a report from FAIR Health given to Axios first. Why i… [+1006 chars]Read More
Just how many Americans are taking GLP1s now Axios
